Wed, March 7, 2012
Tue, March 6, 2012
[ Tue, Mar 06th 2012 ] - Market Wire
Verotoxin and E. coli 0157
Mon, March 5, 2012
[ Mon, Mar 05th 2012 ] - Market Wire
Sienna Gold Warrants Extended
[ Mon, Mar 05th 2012 ] - Market Wire
30 a.m. ET
Fri, March 2, 2012
Thu, March 1, 2012
Wed, February 29, 2012
Tue, February 28, 2012
[ Tue, Feb 28th 2012 ] - Market Wire
Alere to Acquire eScreen, Inc.
[ Tue, Feb 28th 2012 ] - Market Wire
ICON Acquires PriceSpective
Mon, February 27, 2012
Sat, February 25, 2012
Fri, February 24, 2012
[ Fri, Feb 24th 2012 ] - Market Wire
BrainStorm Featured on CNBC
Thu, February 23, 2012

Synta to Present at the Cowen and Company 32nd Annual Health Care Conference


//health-fitness.news-articles.net/content/2012/ .. -company-32nd-annual-health-care-conference.html
Published in Health and Fitness on Wednesday, February 29th 2012 at 13:27 GMT by Market Wire   Print publication without navigation


LEXINGTON, Mass.--([ ])--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the Company will be presenting at the Cowen and Company 32nd Annual Health Care Conference on Wednesday, March 7 at 8:00 a.m. (ET) in Boston.

A live audio [ webcast ] and replay of the panel will be available on the "Investors" section of the Company's website, [ www.syntapharma.com ].

About Synta Pharmaceuticals

Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. Synta has a unique chemical compound library, an integrated discovery engine, and a diverse pipeline of clinical- and preclinical-stage drug candidates with distinct mechanisms of action and novel chemical structures. All Synta drug candidates were invented by Synta scientists using our compound library and discovery capabilities. For more information, please visit [ www.syntapharma.com ].


Publication Contributing Sources